Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…
Read More

Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…
Read More
Pharmaceutical giant Pfizer has entered into a strategic research collaboration and licensing agreement with Enodia Therapeutics valued at upwards of…
Read More
Eli Lilly and Company has significantly deepened its footprint in cutting-edge drug discovery by expanding its strategic partnership and licensing…
Read More
In a strategic move to fortify its oncology portfolio against looming patent expirations, MSD—known as Merck & Co. in the…
Read More
Swiss pharmaceutical giant Roche, acting through its subsidiary Genentech, has entered a blockbuster agreement with Earendil Labs, committing up to…
Read More
In a landmark agreement that underscores the surging therapeutic potential of proximity biology, Swiss pharmaceutical giant Roche has joined forces…
Read More
The biopharmaceutical industry is experiencing a significant resurgence in merger and acquisition (M&A) activity, driven by a wave of high-value…
Read More
Medvi, a telehealth company recently profiled by The New York Times as an AI-powered success story, is projected by its…
Read More